In order to confirm the role of NRF2-BCRP signaling in regulating the sensitivity to PDT, we examined the effect of NRF2 knockdown on PDT response in the colon carcinoma HT29 cell line. This evidence concerns the gene NFE2L2 and colon carcinoma.